FDA Grants Breakthrough Therapy Status to UCB's Cimzia in High-Risk APS Pregnancy UCB received FDA Breakthrough Therapy Designation for studying Cimzia in...
https://www.narrowit.com/news/ucb-cimzia-fda-breakthrough-therapy-aps-pregnancy-2026-09-10
#UCB #Cimzia #FDA #AntiphospholipidSyndrome
